Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses.

Area of Science:

• Immunology
• Neuroscience
• Endocrinology

Background:

• Amyloid deposition is a key feature of Alzheimer's disease (AD) and type 2 diabetes.
• Amyloid fibrils' role in innate immunity activation is debated.
• Evidence suggests amyloid proteins may protect against autoimmune conditions.

Purpose of the Study:

• To investigate the protective role of amyloid proteins and their analogs against autoimmune diseases.
• To explore the mechanisms by which amyloid structures modulate immune responses.
• To assess the therapeutic potential of amyloid-based strategies in regenerative medicine.

Main Methods:

• Analysis of AD patient data regarding autoimmune risks post-amyloid plaque clearance.
• Administration of amyloidogenic peptides in experimental autoimmune encephalomyelitis (EAE) models.
• Genetic manipulation of amyloid precursor proteins in EAE models.
• Examination of islet amyloid presence in autoimmune diabetes and polyendocrine syndromes.
• Evaluation of islet amyloid polypeptide (IAPP) agonists and antagonists in diabetes care.
• Assessment of regulatory T cell (Treg) signaling pathways in amyloidosis.

Main Results:

• Targeting AD amyloid plaques increased autoimmune destruction risk.
• Amyloidogenic peptides ameliorated EAE signs.
• Genetic deletion of amyloid precursor proteins exacerbated EAE.
• Absence of islet amyloid correlated with insulitis in autoimmune diabetes.
• IAPP agonists improved diabetes management.
• Amyloidosis activated common Treg suppressive pathways.

Conclusions:

• Amyloid proteins (monomers, oligomers, fibrils) exhibit dual immune modulation, maintaining homeostasis.
• Amyloid proteins offer protection against autoimmune destruction.
• Amyloid-based therapies present a novel approach for regenerative medicine in degenerative diseases.